Indian Watchdog Questions $3B Sun Pharma-Ranbaxy Deal
India regulators are taking a harder look at the planned $3.2 billion merger of Ranbaxy Laboratories Ltd. and Sun Pharmaceuticals Inc. opening the deal that would create the largest pharmaceutical company...To view the full article, register now.
Already a subscriber? Click here to view full article